» Articles » PMID: 18768779

New Insights into Metabolic Signaling and Cell Survival: the Role of Beta-O-linkage of N-acetylglucosamine

Overview
Specialty Pharmacology
Date 2008 Sep 5
PMID 18768779
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The involvement of glucose in fundamental metabolic pathways represents a core element of biology. Late in the 20th century, a unique glucose-derived signal was discovered, which appeared to be involved in a variety of cellular processes, including mitosis, transcription, insulin signaling, stress responses, and potentially, Alzheimer's disease, and diabetes. By definition, this glucose-fed signaling system was a post-translational modification to proteins. However, unlike classical cotranslational N-glycosylation occurring in the endoplasmic reticulum and Golgi apparatus, this process occurs elsewhere throughout the cell in a highly dynamic fashion, similar to the quintessential post-translational modification, phosphorylation. This more recently described post-translational modification, the beta-O-linkage of N-acetylglucosamine (i.e., O-GlcNAc) to nucleocytoplasmic proteins, represents an under-investigated area of biology. This signaling system operates in all of the tissues examined and seems to have persisted throughout all multicellular eukaryotes. Thus, it comes with little surprise that O-GlcNAc signaling is an integral system and viable target for biomedical investigation. This system may be a boundless source for insight into a variety of diseases and yield numerous opportunities for drug design. This Perspective will address recent insights into O-GlcNAc signaling in the cardiovascular system as a paradigm for its involvement in other biological systems.

Citing Articles

An Overview of Glycosylation and its Impact on Cardiovascular Health and Disease.

Loaeza-Reyes K, Zenteno E, Moreno-Rodriguez A, Torres-Rosas R, Argueta-Figueroa L, Salinas-Marin R Front Mol Biosci. 2021; 8:751637.

PMID: 34869586 PMC: 8635159. DOI: 10.3389/fmolb.2021.751637.


Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.

Dassanayaka S, Brittian K, Long B, Higgins L, Bradley J, Audam T PLoS One. 2020; 15(11):e0242250.

PMID: 33253217 PMC: 7703924. DOI: 10.1371/journal.pone.0242250.


O-linked β-N-acetylglucosamine modification of proteins is activated in post-ischemic brains of young but not aged mice: Implications for impaired functional recovery from ischemic stress.

Liu S, Sheng H, Yu Z, Paschen W, Yang W J Cereb Blood Flow Metab. 2015; 36(2):393-8.

PMID: 26661187 PMC: 4759674. DOI: 10.1177/0271678X15608393.


High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.

Dassanayaka S, Readnower R, Salabei J, Long B, Aird A, Zheng Y Biochem J. 2015; 467(1):115-26.

PMID: 25627821 PMC: 4408906. DOI: 10.1042/BJ20141018.


Protein O-GlcNAcylation and cardiovascular (patho)physiology.

Marsh S, Collins H, Chatham J J Biol Chem. 2014; 289(50):34449-56.

PMID: 25336635 PMC: 4263852. DOI: 10.1074/jbc.R114.585984.


References
1.
Xing D, Feng W, Not L, Miller A, Zhang Y, Chen Y . Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. Am J Physiol Heart Circ Physiol. 2008; 295(1):H335-42. PMC: 2494765. DOI: 10.1152/ajpheart.01259.2007. View

2.
Dentin R, Hedrick S, Xie J, Yates 3rd J, Montminy M . Hepatic glucose sensing via the CREB coactivator CRTC2. Science. 2008; 319(5868):1402-5. DOI: 10.1126/science.1151363. View

3.
Jones S, Bolli R . The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol. 2005; 40(1):16-23. DOI: 10.1016/j.yjmcc.2005.09.011. View

4.
Hanover J, Cohen C, Willingham M, Park M . O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins. J Biol Chem. 1987; 262(20):9887-94. View

5.
Kristensen J, Maeng M, Mortensen U, Berg J, Rehling M, Nielsen T . Lack of cardioprotection from metabolic support with glutamine or glutamate in a porcine coronary occlusion model. Scand Cardiovasc J. 2005; 39(1-2):115-20. DOI: 10.1080/14017430510009078. View